Triple negative mixed metaplastic breast carcinoma with squamous and spindle cells in an 84-year-old woman: a rare entity with unclear management strategy and poor prognosis.

Srujitha Murukutla, Vijaya Raj Bhatt, Abhirami Vivekanandarajah, Cynara Coomer, Shilpi Gupta

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Metaplastic carcinoma of the breast, a rare neoplasm, usually presents at an advanced stage, metastasises to distant sites more frequently, has higher Ki-67 expression and is more often triple negative compared with other invasive breast cancers. Here, the authors discuss a case of an 84-year-old woman with triple negative mixed metaplastic breast carcinoma treated with radical modified mastectomy, axillary lymph node dissection and radiation therapy. Because of the rarity of the disease, the pathogenesis and the management remain controversial, thus contributing to overall poor prognosis.

Original languageEnglish (US)
JournalBMJ case reports
Volume2012
StatePublished - 2012

Fingerprint

Epithelial Cells
Breast Neoplasms
Modified Radical Mastectomy
Disease Management
Lymph Node Excision
Radiotherapy
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Triple negative mixed metaplastic breast carcinoma with squamous and spindle cells in an 84-year-old woman : a rare entity with unclear management strategy and poor prognosis. / Murukutla, Srujitha; Bhatt, Vijaya Raj; Vivekanandarajah, Abhirami; Coomer, Cynara; Gupta, Shilpi.

In: BMJ case reports, Vol. 2012, 2012.

Research output: Contribution to journalArticle

@article{7db4f38f73fa4612b2f1a2ef4ac8a0db,
title = "Triple negative mixed metaplastic breast carcinoma with squamous and spindle cells in an 84-year-old woman: a rare entity with unclear management strategy and poor prognosis.",
abstract = "Metaplastic carcinoma of the breast, a rare neoplasm, usually presents at an advanced stage, metastasises to distant sites more frequently, has higher Ki-67 expression and is more often triple negative compared with other invasive breast cancers. Here, the authors discuss a case of an 84-year-old woman with triple negative mixed metaplastic breast carcinoma treated with radical modified mastectomy, axillary lymph node dissection and radiation therapy. Because of the rarity of the disease, the pathogenesis and the management remain controversial, thus contributing to overall poor prognosis.",
author = "Srujitha Murukutla and Bhatt, {Vijaya Raj} and Abhirami Vivekanandarajah and Cynara Coomer and Shilpi Gupta",
year = "2012",
language = "English (US)",
volume = "2012",
journal = "BMJ Case Reports",
issn = "1757-790X",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Triple negative mixed metaplastic breast carcinoma with squamous and spindle cells in an 84-year-old woman

T2 - a rare entity with unclear management strategy and poor prognosis.

AU - Murukutla, Srujitha

AU - Bhatt, Vijaya Raj

AU - Vivekanandarajah, Abhirami

AU - Coomer, Cynara

AU - Gupta, Shilpi

PY - 2012

Y1 - 2012

N2 - Metaplastic carcinoma of the breast, a rare neoplasm, usually presents at an advanced stage, metastasises to distant sites more frequently, has higher Ki-67 expression and is more often triple negative compared with other invasive breast cancers. Here, the authors discuss a case of an 84-year-old woman with triple negative mixed metaplastic breast carcinoma treated with radical modified mastectomy, axillary lymph node dissection and radiation therapy. Because of the rarity of the disease, the pathogenesis and the management remain controversial, thus contributing to overall poor prognosis.

AB - Metaplastic carcinoma of the breast, a rare neoplasm, usually presents at an advanced stage, metastasises to distant sites more frequently, has higher Ki-67 expression and is more often triple negative compared with other invasive breast cancers. Here, the authors discuss a case of an 84-year-old woman with triple negative mixed metaplastic breast carcinoma treated with radical modified mastectomy, axillary lymph node dissection and radiation therapy. Because of the rarity of the disease, the pathogenesis and the management remain controversial, thus contributing to overall poor prognosis.

UR - http://www.scopus.com/inward/record.url?scp=84873113273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873113273&partnerID=8YFLogxK

M3 - Article

C2 - 22665553

AN - SCOPUS:84873113273

VL - 2012

JO - BMJ Case Reports

JF - BMJ Case Reports

SN - 1757-790X

ER -